Former Titan Spine executive joins Vivex Biologics

Written by Alan Condon | February 14, 2020 | Print  |

Regenerative medicine company Vivex Biologics appointed Chad Kolean as CFO Feb. 12.

Mr. Kolean joins from spinal implant developer Titan Spine, which was acquired by Medtronic last year. 

Previously he served as CFO and treasurer for Cellectar Biosciences and Pioneer Surgical Technology, before it merged with RTI Surgical.

Early in his career, Mr. Kolean held several leadership positions within the healthcare and finance sectors, including Tomotherapy, Metavante Corp. and Arthur Andersen.

More articles on devices:
Spinal fusion will be performed for 'decades to come': Key thoughts from 4 surgeons
Challenges facing private practices in spine, and strategies to tackle them
10 numbers that show how big Johnson & Johnson is in spine, orthopedics

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers